Literature DB >> 17028534

[Consultations with infectious disease specialists for patients in a teaching hospital: Adherence in 174 cases].

Marie Méan1, Patricia Pavese, Emilie Tudela, Kim-Anh Dinh-Van, Marie-Reine Mallaret, Jean-Paul Stahl.   

Abstract

OBJECTIVES: In a teaching hospital where infectious disease specialists were routinely consulted for infections in patients in other departments, we sought to assess adherence to the specialists' recommendations, identify the factors influencing adherence, and measure the proportion of nosocomial infections among these consultations.
METHODS: We collected data from intrahospital consultations with infectious disease specialists over a 4-week period. Afterwards (48 hours later), a physician and pharmacist collected all prescriptions for anti-infectious agents (dose, drug, combinations) and other orders (laboratory tests, radiology examination, isolation) for each patient.
RESULTS: There were 174 infectious disease consultations requested for 143 inpatients during the study period. Anti-infectious agents were prescribed for 52.4% of patients, modified for 22.4%, and stopped for 9.1%; 16.1% neither had nor required such treatment. The rate of adherence to the specialists' recommendations was 84.6% for anti-infectious prescriptions and 77.4% for other orders. The factors associated with adherence were a bedside consultation (p = 0.04) and a recommendation to stop rather than modify anti-infectious treatment (p = 0.02). Roughly 40% of the patients (n = 57) had a nosocomial infection, most often during hospitalization for surgery (53.1% versus 29.1%, p < 0.01). Consultations were requested for 20% of the nosocomial infections observed at Grenoble University Hospital (based on annual prevalence in 2005).
CONCLUSIONS: The specialist's presence at the patient's bedside has an impact on staff adherence to recommendations. These specialists play a vital role in managing nosocomial infections, which account for more than a third of these intrahospital' consultations.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17028534     DOI: 10.1016/s0755-4982(06)74835-7

Source DB:  PubMed          Journal:  Presse Med        ISSN: 0755-4982            Impact factor:   1.228


  6 in total

1.  Clinical benefit of infectious diseases consultation: a monocentric prospective cohort study.

Authors:  A de La Blanchardière; J Boutemy; P Thibon; J Michon; R Verdon; V Cattoir
Journal:  Infection       Date:  2012-06-22       Impact factor: 3.553

2.  Unsolicited post-prescription antibiotic review in surgical and medical wards: factors associated with counselling and physicians' compliance.

Authors:  P Lesprit; C Landelle; C Brun-Buisson
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2012-08-24       Impact factor: 3.267

3.  Prospective study of telephone calls to a hotline for infectious disease consultation: analysis of 7,863 solicited consultations over a 1-year period.

Authors:  S Gennai; P François; E Sellier; J-P Vittoz; V Hincky-Vitrat; P Pavese
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2010-11-11       Impact factor: 3.267

4.  Prospective assessment of fluoroquinolone use in a teaching hospital.

Authors:  M Méan; P Pavese; J P Vittoz; L Foroni; C Decouchon; J P Stahl; P François
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2006-12       Impact factor: 3.267

5.  Adherence to recommendations by infectious disease consultants and its influence on outcomes of intravenous antibiotic-treated hospitalized patients.

Authors:  María-Carmen Fariñas; Gabriela Saravia; Jorge Calvo-Montes; Natividad Benito; Juan-José Martínez-Garde; Concepción Fariñas-Alvarez; Lorenzo Aguilar; Ramón Agüero; José-Antonio Amado; Luis Martínez-Martínez; Manuel Gómez-Fleitas
Journal:  BMC Infect Dis       Date:  2012-11-09       Impact factor: 3.090

6.  [History of the infectious disease specialty in Spain].

Authors:  José María Aguado García; José Antonio Iribarren Loyarte; Jesús Gómez Mateos; Félix Gutiérrez Rodero; Ferrán Segura Porta
Journal:  Enferm Infecc Microbiol Clin       Date:  2008-12       Impact factor: 1.731

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.